About the Authors
- Gustaf Ahlén
-
Contributed equally to this work with: Gustaf Ahlén, Lena Strindelius
* E-mail: gustaf.ahlen@ki.se
Affiliation Recopharma AB, Stockholm, Sweden
- Lena Strindelius
-
Contributed equally to this work with: Gustaf Ahlén, Lena Strindelius
Affiliation Recopharma AB, Stockholm, Sweden
- Tomas Johansson
-
Affiliation Recopharma AB, Stockholm, Sweden
- Anki Nilsson
-
Affiliation Recopharma AB, Stockholm, Sweden
- Nathalie Chatzissavidou
-
Affiliation Recopharma AB, Stockholm, Sweden
- Magnus Sjöblom
-
Affiliation Biochemical and Chemical Process Engineering, Luleå University of Technology, Luleå, Sweden
- Ulrika Rova
-
Affiliation Biochemical and Chemical Process Engineering, Luleå University of Technology, Luleå, Sweden
- Jan Holgersson
-
Affiliation Clinical Chemistry and Transfusion Medicine, Sahlgrenska Academy, Gothenburg, Sweden
Competing Interests
JH is acting CEO, board member and shareholder of Recopharma AB. At the time of the study, GA, LS, TJ, AN, and NC were employees of Recopharma. MS has been partly funded by Recopharma through a research grant to LTU. The technology described in the manuscript has been patent-sought by Recopharma, “Production of Human Glycosylated Proteins in Yeast and Methods of Use Thereof” (United States application number 11/626156. Filing date 23-Jan-2007.) (WO application number PCT/IB2007/004164. Filing date 23-Jan-2007.) This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: GA LS JH UR. Performed the experiments: GA LS TJ NC MS. Analyzed the data: GA LS TJ JH. Contributed reagents/materials/analysis tools: TJ AN NC MS. Wrote the paper: GA LS TJ MS JH.